Collaborative research efforts with scientists from Janssen, the Scripps Research Institute, the University of Hong Kong, the University of Pennsylvania and more has led to success in creating a promising novel long-lasting llama-derived antibody therapy for influenza.
Browsing: Viral > Influenza
Roche has announced the FDA approval of Xofluza™, the first and only single-dose oral medicine approved to treat flu.
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
A high-fiber diet can boost the immune response and increase survival in mice infected with influenza virus, according to new research.
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
A proof-of-concept study has demonstrated promise for a new vaccine production platform, which was used to build a prototype synthetic flu vaccine.
In this interview, take a look behind the scenes of a recent Future Microbiology review on influenza virus infection in pregnancy with author, Lucy Somerville.
Researchers have identified that two flu strains are associated with changes to hippocampal structure and function in female mice alongside memory impairment – posing a threat to healthy brain function.
Take a look at the top news stories of the week, including a focus on antimicrobial resistance and industry, and new influenza research.